A vitamin supplement that improves metabolism in the eye appears to slow down damage to the optic nerve in glaucoma. The researchers behind the study have now started a clinical trial on patients.
source https://www.sciencedaily.com/releases/2025/05/250508112321.htm
Sulfolobus islandicus: Expanding the genetic toolkit for drug delivery and
biotechnology applications
-
Sulfolobus islandicus, an archaeal model organism, offers unique advantages
for metabolic engineering and synthetic biology applications owing to its
abili...
21 hours ago
No comments:
Post a Comment